Image-derived conjunctival hyperemia and clinical ocular surface changes after initiation of topical glaucoma therapy: a prospective longitudinal pilot study
Abstract
Topical glaucoma therapy can affect the ocular surface, but objective longitudinal data on conjunctival hyperemia are limited. We prospectively followed 31 patients naive to topical antiglaucoma therapy for 24 weeks after treatment initiation, analyzing one baseline severity-selected eye per participant. All 31 participants contributed complete analyzable conjunctival image series at baseline and 6, 12, and 24 weeks. Automated image processing quantified strong red area as the primary hyperemia metric and blood vessel area as a secondary metric. Tear breakup time (TBUT), Schirmer I testing, National Eye Institute (NEI) corneal staining, Ocular Surface Disease Index (OSDI), and NEI Visual Function Questionnaire-25 were also assessed. Strong red area increased numerically by 2.56 percentage points at 24 weeks (95% CI − 1.06 to 6.18; P = 0.165), while blood vessel area remained stable. NEI staining decreased, TBUT and Schirmer I showed no significant overall change, OSDI scores decreased (overall P = 0.002), and NEI-VFQ-25 scores improved. Over 24 weeks, image-derived conjunctival hyperemia showed no statistically significant persistent increase, whereas clinical ocular-surface signs and patient-reported outcomes followed differing trajectories. These preliminary findings characterize ocular-surface changes after initiation of topical glaucoma therapy, although the small uncontrolled design precludes causal or equivalence conclusions.
Related
- Efficacy and safety of trans-fornix conjunctival retrobulbar block in a prospective randomized controlled trial
- Longitudinal Clinical and Functional Outcomes in Adult-Onset Delusional Disorder and Schizophrenia: A 10-Year Prospective Comparison Study
- Comparative Evaluation of Postoperative Corneal Astigmatic Correction Following Pterygium Excision by Bare Sclera Technique Versus Conjunctival Limbal Autograft: A Prospective Observational Study
- Anatomopathological Aspects and Clinical Correlation of Conjunctival Bleb Fibrosis Following Encapsulation of a Biodegradable Collagen Matrix Implant in Glaucoma Surgery
- Clinical and Radiomics Predictors of Post-stroke Longitudinal Mortality: A Prospective Cohort Study from a Tertiary Care Hospital in India
BibTeX
@article{hansapinyo2026imagederived,
title = {{Image-derived conjunctival hyperemia and clinical ocular surface changes after initiation of topical glaucoma therapy: a prospective longitudinal pilot study}},
author = {Linda Hansapinyo and Nicha Pianwichanpong and Kessara Pathanapitoon and Chanut Hansapinyo and Nutt Hansapinyo and Pichaya Kulniwatcharoen and Karn Patanukhom},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73990-x},
url = {https://www.nature.com/articles/s41598-026-73990-x},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Image-derived conjunctival hyperemia and clinical ocular surface changes after initiation of topical glaucoma therapy: a prospective longitudinal pilot study
AU - Linda Hansapinyo
AU - Nicha Pianwichanpong
AU - Kessara Pathanapitoon
AU - Chanut Hansapinyo
AU - Nutt Hansapinyo
AU - Pichaya Kulniwatcharoen
AU - Karn Patanukhom
PY - 2026
DA - 2026/10/07
JO - Scientific Reports
DO - 10.1038/s41598-026-73990-x
UR - https://www.nature.com/articles/s41598-026-73990-x
AB - Topical glaucoma therapy can affect the ocular surface, but objective longitudinal data on conjunctival hyperemia are limited. We prospectively followed 31 patients naive to topical antiglaucoma therapy for 24 weeks after treatment initiation, analyzing one baseline severity-selected eye per participant. All 31 participants contributed complete analyzable conjunctival image series at baseline and 6, 12, and 24 weeks. Automated image processing quantified strong red area as the primary hyperemia metric and blood vessel area as a secondary metric. Tear breakup time (TBUT), Schirmer I testing, National Eye Institute (NEI) corneal staining, Ocular Surface Disease Index (OSDI), and NEI Visual Function Questionnaire-25 were also assessed. Strong red area increased numerically by 2.56 percentage points at 24 weeks (95% CI − 1.06 to 6.18; P = 0.165), while blood vessel area remained stable. NEI staining decreased, TBUT and Schirmer I showed no significant overall change, OSDI scores decreased (overall P = 0.002), and NEI-VFQ-25 scores improved. Over 24 weeks, image-derived conjunctival hyperemia showed no statistically significant persistent increase, whereas clinical ocular-surface signs and patient-reported outcomes followed differing trajectories. These preliminary findings characterize ocular-surface changes after initiation of topical glaucoma therapy, although the small uncontrolled design precludes causal or equivalence conclusions.
SN - 2045-2322
ER -